Navigation Links
Beneficial or not beneficial: that is the question for IL-1 inhibition in atherosclerosis
Date:12/27/2011

Atherosclerosis is a disease of the major arterial blood vessels. It is one of the major causes of heart attack and stroke. The proinflammatory molecule IL-1 has been linked to atherosclerosis and a clinical trial has been launched in which an antibody specific for IL-1-beta is being studied for its effects on the severe clinical complications of atherosclerosis (i.e., heart attack and stroke).

However, a team of researchers led by Gary Owens, at the University of Virginia, Charlottesville, has now generated data in mice that raise potential concerns about this clinical trial Owens and colleagues find that IL-1 limits the features of advanced atherosclerosis that are linked to the severe complications of the disease in humans.


'/>"/>

Contact: Karen Honey
karen.honey@the-jci.org
Journal of Clinical Investigation
Source:Eurekalert

Page: 1

Related medicine news :

1. Removal of lymph nodes during surgery for thyroid cancer may be beneficial
2. Vermicompost beneficial for organically grown tomatoes
3. CT scans for lung cancer screening may be beneficial in detecting COPD
4. Experts find continuous glucose monitoring beneficial in maintaining target blood glucose levels
5. Combination therapy beneficial for head and neck skin carcinomas, UNC study shows
6. Shorter treatment with hepatitis C drug combination may be more beneficial, study shows
7. Blood test for colon cancer screening beneficial for some seniors, but not for many others
8. Aggressive Treatment May Be Beneficial for Early Prostate Cancer
9. Antibiotic may prove beneficial to preterm infant lung health
10. Nighttime sleep found beneficial to infants skills
11. Beneficial effects of testosterone for frailty in older men are short-lived
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 2017 , ... Via Oncology, the leading provider of oncology ... public-facing tool for analyzing the costs of various drug regimens in cancer care. ... patients, providers, insurers and pharmaceutical companies about the estimated costs of treatment options. ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Radiology Business Management Association (RBMA) ... as its new executive director. Mr. Still was selected through a careful months-long search ... as he is known to our members, has been a part of building the ...
(Date:3/28/2017)... ... March 28, 2017 , ... With less than 10,000 dermatologists ... to quality care can be limited while the desire to conquer breakouts and eliminate ... acne care for every customer online, today released its inaugural survey on the State ...
(Date:3/28/2017)... ... March 28, 2017 , ... A minimally invasive ... “perfect smile.” The National Association of Dental Laboratories (NADL) is informing dentists about ... aware of when utilizing dental laboratories and technicians that create these veneers. ...
(Date:3/28/2017)... ... March 28, 2017 , ... With expansion and efficiency in mind, ... March. , The seed processing plant opened in Marshallville in 2006, and a bagging ... office allows opportunity for transition of Patten Seed operations to the Middle Georgia location ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... March 28, 2017 RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Japan Patent Office (JPO) for the composition ... factor (CTGF) for the treatment or prevention of ... fibrosis and proliferative retinopathy (Japanese Patent #: 6060071).  ...
(Date:3/28/2017)... 2017 The global flow ... billion by 2025, according to a new study by ... diseases and cancer is expected to upsurge the demand ... the coming years. In addition, higher number of physicians ... stem cell therapy, due to adverse effects caused by ...
(Date:3/28/2017)... Elysium Health joins major pharmaceutical companies to ... Cambridge academic scientists through ... Institute today announces Elysium Health as a partner to the ... collaborative projects with academic researchers in Cambridge ... major research investment outside the U.S. for the ...
Breaking Medicine Technology: